Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Standard of Care × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Hematologic Neoplasms 2 Carcinoma, Squamous Cell 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Tobacco Use 1 Teratoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Skin Neoplasms 1 Skin Carcinoma 1 Sarcopenia 1 Sarcoglycanopathies 1 Renal Insufficiency, Chronic 1 Progressive Metastatic Castrate Resistant Prostate Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Ovarian Neoplasms 1

Interventions

Tamoxifen 3 Specimen Handling 3 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Starch 1 Standard of Care 1 Radiotherapy 1 Radiation 1 Practice Guidelines as Topic 1 Observation 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Biopsy 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04906200 2026-02-19

YES

Ohio State University Comprehensive Cancer Center

Phase NA Active not recruiting

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡